Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Adrian M. Senderowicz
Age : 56
Public asset : 210,885 USD
Linked companies : Puma Biotechnology, Inc.
Summary 
Adrian M. Senderowicz is on the board of Puma Biotechnology, Inc.

In the past he held the position of Chief Medical Officer & Senior Vice President for Constellation Pharmaceuticals, Inc., Chief Medical Officer & Senior Vice President at DarÚ Bioscience, Inc. and Chief Medical Officer & Senior Vice President at Cerulean Pharma, Inc. (a subsidiary of DarÚ Bioscience, Inc.), Senior Medical Director-Oncology Division at AstraZeneca Plc, Vice President-Global Regulatory Oncology at Sanofi, Chief Medical Officer & VP-Medical Development at Tokai Pharmaceuticals, Inc., Chief Medical Officer & SVP-Regulatory Affairs at Ignyta, Inc., Head-Prostate Cancer Clinic at National Institutes of Health and Clinical Team Leader-Oncology Division at US Food & Drug Administration.

Adrian M. Senderowicz received a doctorate from Universidad de Buenos Aires.


Current positions of Adrian M. Senderowicz 
NameTitle Since
Puma Biotechnology, Inc.
(Biotechnology & Medical Research)
Independent Director 2015


Holdings of Adrian M. Senderowicz 
NameEquities%Valuation
Puma Biotechnology, Inc. (PBYI)
(Biotechnology & Medical Research)
27,8580.068%210,885 USD


Adrian M. Senderowicz: Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Adrian M. Senderowicz : Connections